Description |
Product Type |
Product Size |
Injection |
1'S |
Product Company |
Sami Pharmaceutical |
Diclofenac Sodium 75mg |
Product Type |
Product Size |
Tablet |
100'S |
Product Company |
Wilson Pharmaceuticals |
Orphenadrine citrate 50mg, paracetamol 650mg |
Product Type |
Product Size |
Tablet |
200'S |
Product Company |
Pfizer/td> |
Mefenamic Acid 500mg |
Product Type |
Product Size |
Tablet |
20'S |
Product Company |
Mass Pharma |
Amlodipine 5mg
|
Product Type |
Product Size |
Product Company |
Injection |
1'S |
AJM Pharmaceuticals |
|
Product Type |
Product Size |
Tablet |
20'S |
Product Company |
Mass Pharma |
Amlodipine 10mg
|
Content | Diclofenac is indicated for use in the treatment of pain and inflammation from varying sources including inflammatory conditions such as osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis, as well as injury-related inflammation due to surgery and physical trauma. | Orphenadrine citrate is a skeletal muscle relaxant. It acts in the central nervous system to produce muscle relaxant effects. Paracetamol is used to treat or prevent pain and reduce fever. | Mefenamic acid is a member of the anthranilic acid derivatives class of nonsteroidal anti-inflammatory drugs, and is used to treat mild to moderate pain. Its name derives from its systematic name, dimethylphenyl aminobenzoic acid. | Amlodipine is in a class of medications called calcium channel blockers. It lowers blood pressure by relaxing the blood vessels so the heart does not have to pump as hard. It controls chest pain by increasing the supply of blood to the heart
| Gemcitabine is a nucleoside metabolic inhibitor used as adjunct therapy in the treatment of certain types of ovarian cancer, non-small cell lung carcinoma, metastatic breast cancer, and as a single agent for pancreatic cancer. | Amlodipine, sold under the brand name Norvasc among others, is a calcium channel blocker medication used to treat high blood pressure and coronary artery disease. It is taken by mouth. |
Reviews
There are no reviews yet.